×
Log in
Get Started
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Explore all categories
Report -
(TSGH Pharmacy Newsletter) · 癌病患有顯著的療效或生存期效益。 目前,FDA 未考慮將Iressa®(gefitinib)從市場中撤回 。新的臨床試驗仍在進行中,俟該試驗完
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form